The following statement is being issued by Rust Consulting, Inc. regarding Huertas et al. v. Aeropres Corp., et al., Case No, 2:21-cv-20021. There is a Proposed Settlement in a class action lawsuit against Aeropres Corporation (“Aeropres”), Aux Sable Liquid Products LP (“Aux Sable”), Bayer HealthCare LLC and Bayer U.S. LLC (collectively, “Bayer”), Beiersdorf Inc., Beiersdorf […]

Frost & Sullivan honors Scala Data Centers with the 2025 Latin American Competitive Strategy Leadership Recognition Scala Data Centers, the leading hyperscale sustainable data center platform in Latin America, has been recognized with the 2025 Latin American Competitive Strategy Leadership Recognition by Frost & Sullivan. This prestigious accolade highlights Scala's strategy and sustainability leadership, rapid

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the AI-driven Precision Oncology Solutions sector for its outstanding achievements in Technology Innovation Leadership. This recognition

Retailers can now access and order from thousands of brands–all directly from within NuOrder and the Lightspeed point of sale system Lightspeed Commerce Inc. (NYSE: LSPD) (TSX: LSPD) (“Lightspeed” or the “Company”), the unified omnichannel platform powering ambitious retail, golf, and hospitality businesses in over 100 countries, today unveiled a new centralized, multi-brand shopping and

Two new launches deliver fan-favorite flavor and elevated indulgence Key News Bites: — NEW Club® Minis Hidden Valley Ranch brings craveable ranch flavor to Club’s bite-sized Minis format — NEW Club® Extra Buttery brings a bolder buttery flavor to the classic Club® cracker — Both innovations begin rolling out nationally starting in January, with expanded

(NASDAQ:AKBA), Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in Praliciguat Phase 2 clinical trial studying focal segmental glomerulosclerosis (FSGS) AKB-097 Phase 2 rare kidney disease basket trial scheduled to begin in 2H 2026 with initial data expected in 2027 CAMBRIDGE, Mass., Jan. 12, 2026

(NasdaqGM:SENS), Preliminary unaudited revenue expected to be approximately $14.2 million for Q4 2025, an increase of 71% year-over-year Introduced 2026 revenue guidance of $58-$62 million Expects to report fourth quarter and full year 2025 financial results on March 2, 2026 GERMANTOWN, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS) a medical

(NasdaqGM:CHAC), TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, today announced the addition of two strategic leaders to their executive team: Michael Trzupek as Chief Financial Officer (CFO) and Natalie Wilmore as Chief Legal Officer (CLO). These executive appointments strengthen Xanadu's leadership as the company

(Other OTC:GLGI),(OTC US:GLGI), TULSA, Okla., Jan. 12, 2026 (GLOBE NEWSWIRE) — (OTCQB:GLGI). Tulsa-based Greystone Logistics, Inc. has scheduled a release of earnings for the Six Months and Three Months Ended November 30, 2025, on Thursday, January 15, 2025, at 7 AM ET. Greystone will provide a teleconference on Thursday, January 15, 2026, at 2:00 PM

BOSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) — NIMA Partners, Inc. today unveiled the next generation of its NIMA(TM) Gluten Sensor, the first handheld gluten detection device reengineered for faster, more dependable results. The smart device sets a new standard as the only portable solution capable of identifying all major gluten sources (wheat, barley, and rye)